Actinomycosis pathophysiology

Jump to navigation Jump to search

Actinomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Actinomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Actinomycosis pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Actinomycosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Actinomycosis pathophysiology

CDC on Actinomycosis pathophysiology

Actinomycosis pathophysiology in the news

Blogs on Actinomycosis pathophysiology

to Hospitals Treating Actinomycosis

Risk calculators and risk factors for Actinomycosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Actinomycosis is a chronic pyogenic bacterial infection caused by Actinomyces species. Infection most frequently follows dental work, trauma, surgery, or other medical conditions. When there is break in the mucosa, anywhere from the mouth to the rectum they reach tissues and cause damage. Incubation period of Actinomycosis varies from one to four weeks. But occasionally, it may be as long as several months. Actinomycosis elicits both humoral and cell-mediated immune responses

Pathophysiology

  • Actinomycosis is caused by the bacteria Actinomyces. The pathophysiology of Actinomycosis can be described in the following steps. [1][2][3][4][5][6]

Transmission

  • Actinomyces are part of natural flora of human body, resides in the oral cavity, lower gastrointestinal tract and urogenital tract.
  • They are nonvirulent under normal conditions
  • When there is a breach in normal mucosal architecture, anywhere from the mouth to the rectum they enter tissues and cause damage.
Types Site of Infection Source of infection
Cervicofacial actinomycosis
  • Neck
  • Jaw
  • Mouth
  • Dental problems like tooth decay
Thoracic

actinomycosis

  • Lungs
  • Pleura
  • Chest wall
  • Mediastinum
  • Inhalation of droplets of contaminated fluid
  • Aspiration of oropharyngeal secretions or gastric contents
  • Direct extension of cervicofacial infection into the mediastinum
  • Transdiaphragmatic or retroperitoneal spread from the abdomen
  • Hematogenous spread
Abdominal actinomycosis Abdomen
  • Secondary to abdominal infections like appendicitis
  • Accidental swallowing of a foreign body such as chicken bone containing the actinomycetes bacteria
  • Penetrating trauma
  • Perforation of the gut (e.g., the colon or appendix)
  • Surgical manipulation of GI tract
Pelvic

actinomycosis

Pelvis
  • Occurs most commonly in woman as the bacteria passes from the female genitals into the pelvis
  • Long-term use of IUD type of contraceptive
Central nervous system

actinomycosis

CNS
  • Secondary to hematogenous spread from primary infection in the lung, abdomen, or pelvis
  • Direct extension from paranasal sinuses, ears, and cervicofacial regions[7]

Incubation

Incubation period of actinomycosis varies from one to four weeks. But occasionally, it may be as long as several months. 

Dissemination

Following transmission, lesions spread by direct extension.

Seeding

  • Once the endogenous bacteria are introduced into the tissues, they multiply due to low oxygen tension.
  • It triggers an inflammatory reaction which results in the formation of hard yellow hard granules(sulfur granules).
  • These granules represent solidified bacterial filaments with surrounding tissue exudates.
  • Inflammatory mediators along with various bacterial toxins and proteolytic enzymes from the neutrophils are released leading to abscess formation.
  • A fibrous wall develops around the abscess along with sulfur granules.
  • Extension of the abscess to skin leads to the formation of sinus tracts and pus drains out through these sinuses.

Immune response

Actinomycosis elicits both humoral and cell-mediated immune responses

Genetics

There is no known genetic association to actinomycosis

Gross Pathology

On gross pathology the following features can be noticed:

  • Single or multiple abscesses
  • Indurated masses with hard fibrous walls and soft central loculations containing white or yellow pus.
  • Granules are seen grossly.
  • Sinus tracts extended from abscesses to the skin surface or into organs; vertebral bone, and retroperitoneal tissue.
  • Pleural, pericardial, or serosal thickening if the infection involves lung, heart, and wall of the bowel.

Microscopic pathology

Microscopic findings include

  • Liquefaction type of necrosis in the center of abscess with a surrounding outer layer of granulation tissue along with lymphocytes and neutrophils.
  • Gram positive organism with branching filaments forming segment-like structures form colonies.
This is a low-power photomicrograph of the retroperitoneal abscess. At this magnification, multiple dark-staining foci can be appreciated. These foci are Actinomyces colonies (arrows). These colonies are known as "sulfur granules" because in gross specimens they are visible to the naked eye as yellow grains, thus resembling grains of sulfur.

\


{{#ev:youtube|pvasI_yy3R4}}

References

  1. Volante M, Contucci AM, Fantoni M, Ricci R, Galli J (2005). "Cervicofacial actinomycosis: still a difficult differential diagnosis". Acta Otorhinolaryngol Ital. 25 (2): 116–9. PMC 2639881. PMID 16116835.
  2. Sharkawy AA (2007). "Cervicofacial actinomycosis and mandibular osteomyelitis". Infect. Dis. Clin. North Am. 21 (2): 543–56, viii. doi:10.1016/j.idc.2007.03.007. PMID 17561082.
  3. Peipert, Jeffrey F. (2004). "Actinomyces: Normal Flora or Pathogen?". Obstetrics & Gynecology. 104 (Supplement): 1132–1133. doi:10.1097/01.AOG.0000145267.59208.e7. ISSN 0029-7844.
  4. Higashi Y, Nakamura S, Ashizawa N, Oshima K, Tanaka A, Miyazaki T, Izumikawa K, Yanagihara K, Yamamoto Y, Miyazaki Y, Mukae H, Kohno S (2017). "Pulmonary Actinomycosis Mimicking Pulmonary Aspergilloma and a Brief Review of the Literature". Intern. Med. 56 (4): 449–453. doi:10.2169/internalmedicine.56.7620. PMID 28202870.
  5. Schaal KP, Lee HJ (1992). "Actinomycete infections in humans--a review". Gene. 115 (1–2): 201–11. PMID 1612438.
  6. Brown, James R. (1973). "Human actinomycosisA study of 181 subjects". Human Pathology. 4 (3): 319–330. doi:10.1016/S0046-8177(73)80097-8. ISSN 0046-8177.
  7. Smego RA (1987). "Actinomycosis of the central nervous system". Rev Infect Dis. 9 (5): 855–65. PMID 3317731.

Template:Bacterial diseases